| Date Filed | Type | Description |
| 07/07/2011 |
BW
| Hi-Tech Pharmacal Reports Record Sales of $57.2 million and Diluted EPS of $1.08 from Continuing Operations for the Fourth Quarter 2011 Ended April 30, 2011 |
| 06/30/2011 |
BW
| Hi-Tech Pharmacal to Release Fourth Quarter Earnings and Hold Conference Call on July 7, 2011 |
| 06/28/2011 |
BW
| Hi-Tech Pharmacal Acquires Rights to Branded Products to be Promoted by their ECR Pharmaceuticals Subsidiary |
| 05/10/2011 |
BW
| Hi-Tech Pharmacal Divests its Midlothian Laboratories Division |
| 04/08/2011 |
BW
| Hi-Tech Pharmacal Receives Tentative Approval for Brimonidine Tartrate with Timolol Maleate Ophthalmic Solution |
| 04/07/2011 |
BW
| Hi-Tech Pharmacal Receives Tentative Approval for Levofloxacin Oral Solution |
| 03/24/2011 |
BW
| Hi-Tech Pharmacal Receives Final Approval for Lidocaine HCl Jelly, 2% |
| 03/22/2011 |
BW
| Hi-Tech Pharmacal Receives Final Approval for Ranitidine Syrup |
| 03/21/2011 |
BW
| Hi-Tech Pharmacal Acquires Nystatin Oral Suspension ANDA |
| 03/10/2011 |
BW
| Hi-Tech Pharmacal Reports Record Sales of $50.0 Million and Earnings Per Share of $0.79 for the Third Fiscal Quarter Ended January 31, 2011 |
| 03/04/2011 |
BW
| Hi-Tech Pharmacal to Release Third Quarter Earnings and Hold Conference Call on March 10, 2011 |
| 03/03/2011 |
BW
| FDA Action Affects Products Marketed by Hi-Tech Pharmacal's ECR Pharmaceuticals Subsidiary |
| 03/01/2011 |
BW
| Hi-Tech Pharmacal to Present at the 2011 RBC Capital Markets' Healthcare Conference |
| 12/09/2010 |
BW
| Hi-Tech Pharmacal Reports Sales of $44.9 Million and EPS of $0.76 for the Second Fiscal Quarter Ended October 31, 2010 |
| 12/03/2010 |
BW
| Hi-Tech Pharmacal to Release Second Quarter Earnings and Hold Conference Call on December 9, 2010 |
| 09/20/2010 |
BW
| Hi-Tech Pharmacal to Present at the UBS Global Life Sciences Conference |
| 09/08/2010 |
BW
| Hi-Tech Pharmacal Reports Sales of $40.4 Million and EPS of $0.67 for the Quarter Ended July 31, 2010 |
| 08/30/2010 |
BW
| Hi-Tech Pharmacal to Release First Quarter Earnings and Hold Conference Call on September 8, 2010 |
| 08/10/2010 |
BW
| Hi-Tech Pharmacal to Present at the Bank of America 2010 Specialty Pharmaceuticals Conference |
| 07/13/2010 |
BW
| Hi-Tech Pharmacal Reports 6% Increase in Sales and 11% Increase in EPS for the Fourth Fiscal Quarter 2010 and a 51% Increase in Sales and an 198% Increase in EPS for Fiscal 2010 |
| 07/07/2010 |
BW
| Hi-Tech Pharmacal to Release Fourth Quarter Earnings and Hold Conference Call on July 13, 2010 |
| 07/01/2010 |
BW
| Hi-Tech Pharmacal Temporarily and Voluntarily Suspends Sales of Certain Products |
| 04/28/2010 |
BW
| Hi-Tech Pharmacal Announces the Hiring of Kamel Egbaria, Ph.D. as Chief Scientific Officer |
| 03/12/2010 |
BW
| Hi-Tech Pharmacal to Present at the Roth 22nd Annual Orange County Growth Stock Conference |
| 03/11/2010 |
BW
| Hi-Tech Pharmacal Reports Results for the Third Fiscal Quarter Ended January 31, 2010 |
| 03/05/2010 |
BW
| Hi-Tech Pharmacal to Release Third Quarter Earnings and Hold Conference Call on March 11, 2010 |
| 03/02/2010 |
BW
| Hi-Tech Pharmacal Acquires Mag-Ox® line of Magnesium Supplements from Blaine Company, Inc. |
| 02/26/2010 |
BW
| Midlothian Laboratories Supports AmeriCares Humanitarian Aid Work |
| 02/16/2010 |
BW
| Hi-Tech Pharmacal's ECR Subsidiary to Co-Promote Unique Kidney Stone Treatment |